21 December 2009
Response to the Mandatory Cash Offer by Recipharm AB ("Recipharm")
16 December 2009
Recipharm announces its intention to acquire Cobra Biomanufacturing Plc
02 November 2009
Completion of GMP manufacture for Scancell’s SCIB1 Clinical Trial
01 September 2009
Cobra Biomanufacturing successfully passes inspection by UK Regulators
26 August 2009
Cobra Biomanufacturing wins new Adenovirus service contract
30 June 2009
Interim Results for the half year ended 31 March 2009
11 May 2009
KAHR Medical and Cobra Partner to Develop Trans Signal Converter Protein Production
06 April 2009
Successful Vaccination Against Anthrax Supports Cobra's Oral Vaccine Delivery Technology
25 March 2009
Preliminary Results for the year ended 30 September 2008
19 January 2009
Hawaii Biotech Inc. finishes Phase I West Nile clinical trial
For further information, please contact:
Julian Hanak
Commercial Services
Tel: +44 (0) 1782 714 181